Search research articles
Contact Us
Filters
Showing results (1-10 of 13) with videos related to
Page
of 2
Sort By:
JAMA
|
September 16, 2010
Graduating US medical students who do not obtain a PGY-1 training position
Henry M Sondheimer
The New England Journal of Medicine
|
April 12, 2013
Holistic review--shaping the medical profession one applicant at a time
Robert A Witzburg, Henry M Sondheimer
Expert Opinion on Biological Therapy
|
August 31, 2007
Palivizumab and the prevention of respiratory syncytial virus illness in pediatric patients with congenital heart disease
Timothy F Feltes, Henry M Sondheimer
Cardiology in the Young
|
March 23, 2007
Current management of ventricular septal defect
Henry M Sondheimer, Kristy Rahimi-Alangi
JAMA
|
December 10, 2015
Placement of US Medical School Graduates Into Graduate Medical Education, 2005 Through 2015
Henry M Sondheimer, Imam M Xierali, Geoffrey H Young, et al.
Academic Medicine : Journal of the Association of American Medical Colleges
|
September 7, 2018
The Association Between a Holistic Review in Admissions Workshop and the Diversity of Accepted Applicants and Students Matriculating to Medical School
Douglas Grbic, Emory Morrison, Henry M Sondheimer, et al.
Cardiology in the Young
|
March 23, 2007
The current state of infection with respiratory syncytial virus in the setting of congenital cardiac malformations
Timothy F Feltes, Richard L Hodinka, Stephen M Paridon, et al.
Journal of Pediatric Gastroenterology and Nutrition
|
February 27, 2003
Hepatic dysfunction following the Fontan procedure
Michael R Narkewicz, Henry M Sondheimer, James W Ziegler, et al.
The Journal of Thoracic and Cardiovascular Surgery
|
October 30, 2004
Evidence of pulmonary vascular disease after heart transplantation for Fontan circulation failure
Max B Mitchell, David N Campbell, Dunbar Ivy, et al.
Pediatric Research
|
April 28, 2011
A randomized controlled trial of motavizumab versus palivizumab for the prophylaxis of serious respiratory syncytial virus disease in children with hemodynamically significant congenital heart disease
Timothy F Feltes, Henry M Sondheimer, Robert M R Tulloh, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 13) with videos related to
Sort By:
Page
of 2
JAMA
|
September 16, 2010
Graduating US medical students who do not obtain a PGY-1 training position
Henry M Sondheimer
The New England Journal of Medicine
|
April 12, 2013
Holistic review--shaping the medical profession one applicant at a time
Robert A Witzburg, Henry M Sondheimer
Expert Opinion on Biological Therapy
|
August 31, 2007
Palivizumab and the prevention of respiratory syncytial virus illness in pediatric patients with congenital heart disease
Timothy F Feltes, Henry M Sondheimer
Cardiology in the Young
|
March 23, 2007
Current management of ventricular septal defect
Henry M Sondheimer, Kristy Rahimi-Alangi
JAMA
|
December 10, 2015
Placement of US Medical School Graduates Into Graduate Medical Education, 2005 Through 2015
Henry M Sondheimer, Imam M Xierali, Geoffrey H Young, et al.
Academic Medicine : Journal of the Association of American Medical Colleges
|
September 7, 2018
The Association Between a Holistic Review in Admissions Workshop and the Diversity of Accepted Applicants and Students Matriculating to Medical School
Douglas Grbic, Emory Morrison, Henry M Sondheimer, et al.
Cardiology in the Young
|
March 23, 2007
The current state of infection with respiratory syncytial virus in the setting of congenital cardiac malformations
Timothy F Feltes, Richard L Hodinka, Stephen M Paridon, et al.
Journal of Pediatric Gastroenterology and Nutrition
|
February 27, 2003
Hepatic dysfunction following the Fontan procedure
Michael R Narkewicz, Henry M Sondheimer, James W Ziegler, et al.
The Journal of Thoracic and Cardiovascular Surgery
|
October 30, 2004
Evidence of pulmonary vascular disease after heart transplantation for Fontan circulation failure
Max B Mitchell, David N Campbell, Dunbar Ivy, et al.
Pediatric Research
|
April 28, 2011
A randomized controlled trial of motavizumab versus palivizumab for the prophylaxis of serious respiratory syncytial virus disease in children with hemodynamically significant congenital heart disease
Timothy F Feltes, Henry M Sondheimer, Robert M R Tulloh, et al.
Page
of 2